Trajectory and risk factors for chemotherapy‐induced nausea and vomiting in Asian patients with head and neck cancer

@article{Chan2015TrajectoryAR,
  title={Trajectory and risk factors for chemotherapy‐induced nausea and vomiting in Asian patients with head and neck cancer},
  author={Alexandre Chan and Maung Shwe and Yan Xiang Gan and Kevin Yi-Lwern Yap and Lita Chew and W-T. Lim},
  journal={Head \& Neck},
  year={2015},
  volume={37}
}
The purpose of this study was to analyze the trajectory of and risk factors for chemotherapy‐induced nausea and vomiting in Asian patients with head and neck cancer. 
View on Wiley
sbccp.org.br
7 Citations
Background Citations
2

7 Citations

Citation Type

Citation Type

The impact of induction and/or concurrent chemoradiotherapy on acute and late patient‐reported symptoms in oropharyngeal cancer: Application of a mixed‐model analysis of a prospective observational cohort registry
The goal of this study was to comprehensively investigate the association of chemotherapy with trajectories of acute symptom development and late symptom recovery in patients with oropharyngeal…
Toxicities Caused by Head and Neck Cancer Treatments and Their Influence on the Development of Malnutrition: Review of the Literature
TLDR
There is an urgent need for the implementation or continuation of multi-disciplinary strategies, as well as updated and improved guidelines to assist in the prevention and treatment of malnutrition caused by treatment-related toxicities in patients with HNC.
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches
TLDR
Several suggestions are made for a practical approach to prevent or manage nausea and vomiting due to chemotherapy regimens and radiation therapy, and an Expert Panel was convened to examine unresolved issues and summarize the current clinical research on managing nausea and vomit associated with combination chemotherapy and radiotherapy.
Applicability of the National Comprehensive Cancer Network/Multinational Association of Supportive Care in Cancer Guidelines for Prevention and Management of Chemotherapy-Induced Nausea and Vomiting in Southeast Asia: A Consensus Statement
TLDR
These regional guidelines provide definitive guidance for CINV management in general and resource-restricted settings and are anticipated to contribute to collaborative efforts to improve CINVs management in Southeast Asia.
Cost-effective use of aprepitant in multiple-day chemotherapy regimens
TLDR
Cost-effectiveness analysis for the use of aprepitant in multiple-day chemotherapy, including FP for head and neck cancer and BEP for germ cell carcinoma, found it to be cost-effective.
Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.
TLDR
An international working group of experts in the fields of cancer-associated thrombosis/hemostasis, hematology, and oncology discussed key issues related to the use of DOACs in patients with VTE or AF and cancer, and developed some consensus recommendations.
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
TLDR
In patients treated with high-dose cisplatin, the daily addition of ginger, even if safe, did not result in a protective effect on CINV, and the favorable effect observed on nausea in subgroups at particular risk of nausea (females; HNC) deserves specific investigation.

References

SHOWING 1-10 OF 27 REFERENCES
Impact of cancer‐related fatigue on chemotherapy‐induced nausea and vomiting in Asian cancer patients
TLDR
This study aims to evaluate the potential of CRF in predicting the occurrence of chemotherapy‐induced nausea and vomiting in patients with confirmed or suspected cancer‐related fatigue.
Quality of life and oral function following radiotherapy for head and neck cancer
TLDR
The purpose of this investigation was to assess the quality of life, oral function, and oral symptoms following radiotherapy for oropharyngeal cancer.
Exploring Chemotherapy-Induced Toxicities through Multivariate Projection of Risk Factors: Prediction of Nausea and Vomiting
TLDR
Fatigue interference and severity were predictive of CINV in anthracycline-based populations, while the former was predictive in HEC and XELOX populations.
Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
TLDR
The prevalence of severe CINV for breast cancer was relatively low compared with the prevalence reported in the literature, and several patient characteristics that predict which patients are at increased risk of developing severe symptoms were identified.
Chemotherapy-induced nausea and vomiting in Asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy.
Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management
TLDR
Extended-release formulations and new delivery systems such as transdermal patches, nasal sprays, and pumps provide a new strategy that may improve patient outcomes.
Computational Prediction of State Anxiety in Asian Patients With Cancer Susceptible to Chemotherapy-Induced Nausea and Vomiting
TLDR
The usefulness of PC analysis, an unsupervised machine learning technique, is demonstrated to identify 7 anxiety characteristics that are useful as clinical CINV predictors, and Clinicians should be aware of these characteristics when assessing CinV in patients on emetogenic chemotherapies.
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.
TLDR
Patients about to receive moderately or highly emetogenic chemotherapy should be screened for these factors and additional measures, such as behavior modification and modification of antiemetic therapy, should be considered in attempts to improve the control of PCNV.
Cancer patients' expectations of experiencing treatment‐related side effects
TLDR
The authors' knowledge, less is known regarding what patients expect to experience regarding these side effects and how patient characteristics are related to these expectations.
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
TLDR
CINV continues to adversely affect patients' QoL despite antiemetic therapy even after treatment with only moderately emetogenic chemotherapy regimens, and even in the subgroup of patients who do not experience nausea and vomiting during the first 24 hours.
...
1
2
3
...